1. TO901317 inhibits the development of hepatocellular carcinoma by LXRα/Glut1 decreasing glycometabolism
   Ting Xiong et al, 2019, American Journal of Physiology-Gastrointestinal and Liver Physiology CrossRef
2. Liver X Receptors (LXRs) in cancer-an Eagle’s view on molecular insights and therapeutic opportunities
   Prasanna Srinivasan Ramalingam et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
3. iTRAQ-Based Proteomic Analysis Reveals Potential Serum Biomarkers for Pediatric Non-Hodgkin’s Lymphoma
   Runhong Yu et al, 2022, Frontiers in Oncology CrossRef
4. In silico molecular modeling and simulations of black tea theaflavins revealed theaflavin-3’-gallate as putative liver X receptor-beta agonist
   Temidayo O. Adigun et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
5. Cancer therapy's impact on lipid metabolism: Mechanisms and future avenues
   Roshni Bhatnagar et al, 2022, Frontiers in Cardiovascular Medicine CrossRef